SYDNEY, AUSTRALIA: , Exopharm Limited has announced an agreement to acquire all issued capital of Tryp Therapeutics Inc. through a Canadian plan of arrangement. The deal will see Tryp shareholders receive 3.616 Exopharm shares for each Tryp share held, marking a substantial shift in Exopharm’s business scale and activities. The acquisition necessitates shareholder approval and…
All posts tagged Tryp Therapeutics
Tryp Therapeutics appoints Greg McKee as Chief Executive Officer
SAN DIEGO: Tryp Therapeutics Inc. has appointed Greg McKee as its Chief Executive Officer, a news release said. Mr. McKee will also continue in his responsibilities as Chairman of the Board of Directors of the Company. Mr. McKee has extensive experience leading publicly traded pharmaceutical companies and brings a vast network of relationships in the…